SEGMENT INFORMATION

9 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

SEGMENT INFORMATION

6. SEGMENT INFORMATION

 

We operate in two principal segments - research services and research products. Our Service segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Product segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2015.

	Three Months Ended  June 30,				Nine Months Ended June 30,
	2016		2015		2016		2015
Revenue:
Service	$	3,773	$	5,001	$	11,881	$	13,929
Product		1,280		1,149		3,406		3,792
	$	5,053	$	6,150	$	15,287	$	17,721
Operating income (loss):
Service	$	(364)	$	1,440	$	(962)	$	1,510
Product		(1)		94		(194)		194
	$	(365)	$	1,534	$	(1,156)	$	1,704
Interest expense		(107)		(67)		(243)		(223)
Change in fair value of warrant liability – decrease		21		34		189		353
Other income		1		—		2		1
Income (loss) before income taxes	$	(450)	$	1,501	$	(1,208)	$	1,835